Canada
· Delayed Price · Currency is CAD MustGrow Biologics Statistics
Total Valuation
MustGrow Biologics has a market cap or net worth of CAD 93.47 million. The enterprise value is 89.32 million.
| Market Cap | 93.47M |
| Enterprise Value | 89.32M |
Important Dates
The next estimated earnings date is Tuesday, November 26, 2024.
| Earnings Date | Nov 26, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MustGrow Biologics has 51.64 million shares outstanding. The number of shares has increased by 2.49% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 51.64M |
| Shares Change (YoY) | +2.49% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 10.48% |
| Owned by Institutions (%) | n/a |
| Float | 45.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.52 |
| PB Ratio | 24.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -210.68 |
| EV / Sales | 18.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.87, with a Debt / Equity ratio of 0.14.
| Current Ratio | 4.87 |
| Quick Ratio | 4.82 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -12.22% and return on invested capital (ROIC) is 1.47%.
| Return on Equity (ROE) | -12.22% |
| Return on Assets (ROA) | 1.20% |
| Return on Capital (ROIC) | 1.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.93 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +61.61% in the last 52 weeks. The beta is 1.67, so MustGrow Biologics's price volatility has been higher than the market average.
| Beta (5Y) | 1.67 |
| 52-Week Price Change | +61.61% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 1.13 |
| Relative Strength Index (RSI) | 52.41 |
| Average Volume (20 Days) | 17,182 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MustGrow Biologics had revenue of CAD 4.71 million and -423,950 in losses. Loss per share was -0.01.
| Revenue | 4.71M |
| Gross Profit | 4.47M |
| Operating Income | 96,697 |
| Pretax Income | -423,950 |
| Net Income | -423,950 |
| EBITDA | n/a |
| EBIT | 96,697 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 4.67 million in cash and 517,991 in debt, giving a net cash position of 4.15 million or 0.08 per share.
| Cash & Cash Equivalents | 4.67M |
| Total Debt | 517,991 |
| Net Cash | 4.15M |
| Net Cash Per Share | 0.08 |
| Equity (Book Value) | 3.75M |
| Book Value Per Share | 0.07 |
| Working Capital | 3.89M |
Cash Flow
| Operating Cash Flow | -187,131 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 94.88%, with operating and profit margins of 2.05% and -9.00%.
| Gross Margin | 94.88% |
| Operating Margin | 2.05% |
| Pretax Margin | -9.00% |
| Profit Margin | -9.00% |
| EBITDA Margin | n/a |
| EBIT Margin | 2.05% |
| FCF Margin | n/a |
Dividends & Yields
MustGrow Biologics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.49% |
| Shareholder Yield | -2.49% |
| Earnings Yield | -0.46% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MustGrow Biologics has an Altman Z-Score of 29.58.
| Altman Z-Score | 29.58 |
| Piotroski F-Score | n/a |